Printer Friendly

Browse Diabetes therapy topic

Product development subtopic

Articles

1-202 out of 202 article(s)
Title Author Type Date Words
United States : PharmaCyte Biotech Successfully Completes All Release Tests on Clinical Trial Product. Jan 27, 2020 325
Arecor boasts "favourable profile" for fast-acting insulin in phase I trial. Dec 6, 2019 350
Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019. Dec 2, 2019 1127
United States : PharmaCyte Biotech Release Testing Successful on All Completed Tests of Clinical Trial Product. Nov 29, 2019 398
United States : PharmaCyte Biotech Closer to Submitting IND by Successfully Completing Encapsulation of Second Manufacturing Run of Clinical Trial Product. Nov 11, 2019 426
Imugene plans to begin Phase 1 oncolytic virus technology clinical trials in 2020. Oct 22, 2019 500
Preliminary PEC-Direct Clinical Data Presented: Insulin Production From Stem Cell-Derived Islet Replacement Therapy. Oct 21, 2019 322
vTv Therapeutics presents additional data from Phase 2 Simplici-T1 study. Sep 18, 2019 172
AstraZeneca reports Farxiga met primary endpoint in Phase 3 DAPA-HF trial. Aug 20, 2019 113
Valeritas reports preclinical data from PK study of Apo delivered via h-Patch. Aug 5, 2019 361
Valeritas Rallies On Positive Preclinical Data For CBD Delivery Using Wearable Device. Jul 30, 2019 456
United Kingdom : Irst Patient Dosing in Phase I Clinical Trial of Ultra-rapid Acting Insulin Product Candidate At247 for Diabetes. Jul 10, 2019 251
Belgium : ActoBio Therapeutics Progresses AG019 to Next Stage of a Phase Ib/IIa Clinical Study for the Treatment of Type 1 Diabetes. Clinical report Jul 5, 2019 514
Intrexon subsidiary ActoBio to move to next stage in AG019 trial. Jul 1, 2019 294
Xeris Pharmaceuticals Touts Additional Positive Outcomes from a Global Phase 3 Clinical Trial of Its Investigational Ready-to-Use Glucagon. Jun 20, 2019 382
Xeris Pharmaceuticals announces findings from Phase 3 liquid glucagon trial. Clinical report Jun 17, 2019 176
ProtoKinetix reaches midpoint of AAGP PKX-001 trial. Jun 11, 2019 137
ProtoKinetix reaches midpoint of AAGP PKX-001 trial. Jun 11, 2019 133
ProtoKinetix Achieves Primary Objective Safety at Midpoint of Clinical Trial. Jun 11, 2019 423
Dance Biopharm Presents Data from Phase 2 Clinical Trial of Dance 501 Inhaled Insulin Therapy at American Diabetes Association Meeting. Jun 11, 2019 326
Zealand Pharma and Beta Bionics complete phase 2 home-use study of dasiglucagon in iLet Bionic Pancreas System. Jun 7, 2019 415
Lannett commences clinical trial of biosimilar insulin glargine. Clinical report Jun 5, 2019 180
PharmaCyte Biotech advances manufacturing process for pancreatic cancer product used in clinical trial. May 8, 2019 163
PharmaCyte Biotech advances manufacturing process for pancreatic cancer product used in clinical trial. May 8, 2019 159
Xeris Pharmaceuticals starts dosing patients in phase two trial with ready-to-use, room-temperature stable liquid glucagon. Mar 18, 2019 186
Xeris Pharmaceuticals starts dosing patients in phase two trial with ready-to-use, room-temperature stable liquid glucagon. Mar 18, 2019 182
Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its Ready-to-Use Glucagon to Address Exercise-Induced Hypoglycemia. Mar 15, 2019 346
Tandem Diabetes trial 'hiccup' can be fixed quickly and easily, says Baird. Mar 6, 2019 103
Novo Nordisk says SUSTAIN 9 Phase 3b trial of Ozempic met primary endpoint. Mar 4, 2019 158
Canada,Pakistan : As a result of the efforts by Dr. Rashid Ahmed and Dr. Rabia Shahab, members of Canada-Pakistan Research & Development Council (CPRDC), Pakistans Indus Hospital selected for Clinical Trials by the University of Manitoba. Dec 10, 2018 196
Canadian university selects Pakistani hospital for clinical trials. Dec 9, 2018 210
United States : PharmaCyte Biotech Engages cGMP Validation to Assist in Preparation of IND for Pancreatic Cancer Trial. Dec 8, 2018 676
Company Publishes "Trial Considerations" For Stem Cell Diabetes Therapy. Nov 19, 2018 371
United States : PharmaCyte Biotech Selects Medpace as CRO for Its Clinical Trial in Pancreatic Cancer. Nov 12, 2018 494
Company Publishes "Trial Considerations" For Stem Cell Diabetes Therapy. Nov 12, 2018 369
Company Publishes "Trial Considerations" For Stem Cell Diabetes Therapy. Nov 12, 2018 369
Zealand Pharma initiates Phase 3 dasiglucagon trial for severe hypoglycemia. Sep 27, 2018 231
Phase III trial shows AstraZeneca diabetes drug cuts heart risks. Sep 24, 2018 207
Phase III trial shows AstraZeneca diabetes drug cuts heart risks. Sep 24, 2018 203
Oramed wins US FDA clearance for IND application for ORMD-0901 to treat type 2 diabetes. Sep 18, 2018 202
US FDA approves Oramed Pharmaceuticals' Investigational New Drug application for human trials of ORMD-0901. Sep 18, 2018 173
Oramed wins US FDA clearance for IND application for ORMD-0901 to treat type 2 diabetes. Sep 18, 2018 198
US FDA approves Oramed Pharmaceuticals' Investigational New Drug application for human trials of ORMD-0901. Sep 18, 2018 169
First trials of revolutionary new diabetes drug are held in Wales. Sep 11, 2018 839
Phase 3 Renal Outcomes Trial of Invokana Stopped Early Based on Positive Efficacy. Jul 23, 2018 320
Empagliflozin Doesn't Up Risk of Bone Fractures; Per pooled data from placebo-controlled trials and data from a head-to-head study with glimepiride. Jul 20, 2018 237
Eli Lilly, Boehringer announce positive phase 3 data for empagliflozin. Jun 25, 2018 145
CohBar presents preclinical data on lead candidate CB4211. Jun 25, 2018 120
Novo Nordisk reports success in two Semaglutide phase 3a trials. Jun 22, 2018 234
Novo Nordisk reports success in two Semaglutide phase 3a trials. Jun 22, 2018 230
Ironwood to highlight clinical, preclinical data on praliciguat at ADA. Jun 20, 2018 240
Zealand Pharma completes second and pivotal Phase 3 trial with dasiglucagon. May 29, 2018 191
Zealand Pharma completes second and pivotal Phase 3 trial with dasiglucagon. May 29, 2018 187
Novo Nordisk says Pioneer 2 Phase 3a trial achieved primary objective. May 29, 2018 322
Zealand Pharma completes Phase 3 trial with dasiglucagon for severe hypoglycemia. May 28, 2018 181
ActoBio Therapeutics to Begin Phase Ib/IIa Trial of AG019 for Treatment of Early Onset T1D. Apr 2, 2018 331
Islet Transplantation Improves Quality of Life in T1DM; Also decreases severe hypoglycemic events; findings among T1DM patients participating in a phase 3 trial. Mar 29, 2018 190
Poxel Initiates Phase 3 Trials of Imeglimin for Treatment of Type 2 Diabetes in Japan. Mar 15, 2018 217
Caladrius reports interim analysis for Phase 2 T-Rex trial of CLBS03 for T1D. Clinical report Mar 8, 2018 102
United States : PharmaCyte Discusses Phase 2b Clinical Trial in Pancreatic Cancer. Mar 3, 2018 406
Novo Nordisk announces completion of the first phase 3a trial, PIONEER 1, with oral semaglutide. Feb 23, 2018 365
Novo Nordisk announces completion of the first phase 3a trial, PIONEER 1, with oral semaglutide. Feb 23, 2018 366
Novo Nordisk announces completion of the first phase 3a trial, PIONEER 1, with oral semaglutide. Feb 23, 2018 361
British Firm Treats First Patient In Phase 3 Trial Of CLI Therapy. Feb 12, 2018 392
BioMarin 'encouraged' by interim data from BMN 250 Phase 1/2 trial. Feb 7, 2018 192
British Firm Treats First Patient In Phase 3 Trial Of CLI Therapy. Feb 5, 2018 393
British Firm Treats First Patient In Phase 3 Trial Of CLI Therapy. Feb 5, 2018 393
Caladrius completes enrollment of Phase 2 T-Rex Study. Clinical report Jan 18, 2018 111
First Patients Implanted In Islet Cell Replacement Trial. Jan 15, 2018 344
First Patients Implanted In Islet Cell Replacement Trial. Jan 8, 2018 363
First Patients Implanted In Islet Cell Replacement Trial. Jan 8, 2018 344
Zealand Pharma announces initiation of phase 3 trial with dasiglucagon. Dec 8, 2017 280
Zealand Pharma announces initiation of phase 3 trial with dasiglucagon. Dec 8, 2017 276
Novo Nordisk's Xultophy a better option to manage type 2 diabetes, DUAL VII clinical trial finds. Dec 5, 2017 251
Novo Nordisk's Xultophy a better option to manage type 2 diabetes, DUAL VII clinical trial finds. Dec 5, 2017 247
Sanofi to start Phase 3 trials of efpeglenatide. Nov 28, 2017 212
Sanofi to start Phase 3 trials of efpeglenatide. Nov 28, 2017 208
DIABETES DRUG CUT HUNGER IN 'STRIKING' TRIALS. Oct 24, 2017 331
Grant To Fund Clinical Trial Of Diabetes Therapy. Oct 9, 2017 377
$20M Grant To Fund Clinical Trial Of Type 1 Diabetes Therapy. Oct 2, 2017 368
$20M Grant To Fund Clinical Trial Of Type 1 Diabetes Therapy. Oct 2, 2017 368
ViaCyte wins CIRM grant in support of clinical trial of PEC-Direct product candidate for high-risk type 1 diabetes. Sep 29, 2017 268
Resverlogix Randomises First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial. Jul 11, 2017 423
Zealand announces initiation of first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycaemia in diabetes. Jul 4, 2017 313
Zealand begins Phase 3 trial with dasiglucagon for treatment of severe hypoglycaemia in diabetes. Jul 3, 2017 225
Boehringer Ingelheim and Eli Lilly begin Phase III studies of empagliflozin. Mar 17, 2017 257
Boehringer Ingelheim and Eli Lilly begin Phase III studies of empagliflozin. Mar 17, 2017 253
$12.2 Million from CIRM supports Phase 2 trial of diabetes treatment. Mar 13, 2017 341
$12.2M grant from CIRM supports phase 2 trial of diabetes treatment. Mar 6, 2017 340
$12.2M grant from CIRM supports phase 2 trial of diabetes treatment. Mar 6, 2017 340
Ligand Completes Enrollment in Phase 2 Trial of LGD-6972 in Type 2 Diabetes. Clinical report Mar 1, 2017 414
Impact of ELKa, the Electronic Device for Prandial Insulin Dose Calculation, on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus: A Randomized Controlled Trial. Kowalska, Agnieszka; Piechowiak, Katarzyna; Ramotowska, Anna; Szypowska, Agnieszka Report Jan 1, 2017 6583
Physical Exercise on Inflammatory Markers in Type 2 Diabetes Patients: A Systematic Review of Randomized Controlled Trials. Melo, Luciana Costa; Dativo-Medeiros, Jaime; Menezes-Silva, Carlos Eduardo; Barbosa, Fabiano Timbo; Report Jan 1, 2017 6883
United States : PharmaCyte Biotech Requests Pre-IND Meeting with FDA for its Pancreatic Cancer Clinical Trial. Nov 2, 2016 486
United States : PharmaCyte Biotech selects Dr. Manuel Hidalgo as Principal Investigator for Its Pancreatic Cancer Clinical Trial. Oct 25, 2016 592
AstraZeneca's Phase III diabetes drug trial meets main goals. Sep 20, 2016 190
AstraZeneca's Phase III diabetes drug trial meets main goals. Sep 20, 2016 186
Germany : Phase III combination trial of Bydureon and Forxiga shows significant benefits in patients with type-2 diabetes. Sep 19, 2016 167
First Patients Enrolled in Omnipod Artificial Pancreas System Clinical Trial. Sep 13, 2016 261
United Kingdom : AstraZeneca announces two new phase IIIb trials for Forxiga in chronic kidney disease and chronic heart failure. Sep 13, 2016 367
Caladrius Biosciences product candidate CLBS03 (autologous expanded polyclonal regulatory T cells, or Tregs) was granted Fast Track designation by the FDA for the treatment of type 1 diabetes mellitus (T1D), making it the first known therapeutic candidate for treatment of T1D to receive the designation. Sep 1, 2016 196
United States : Merck Announces U.S. FDA Filing Acceptance of New Drug Application (NDA) for MK-1293, an Investigational Follow-On Biologic Insulin Glargine. Aug 6, 2016 296
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre doubleblind, placebo-controlled, randomised phase 3 trial. Aug 1, 2016 529
Clinical trial of needle-eliminating type 1 diabetes treatment. Jul 25, 2016 326
Clinical trial of needle-eliminating type 1 diabetes treatment. Jul 25, 2016 326
United States : New Phase 2 Proof-of-Concept Study Shows Canagliflozin Combination Therapy May Support Chronic Weight Management. Jun 15, 2016 165
BioMarin Pharmaceutical enrols for Phase 1/2 trial of BMN 250. Apr 25, 2016 270
BioMarin Pharmaceutical enrols for Phase 1/2 trial of BMN 250. Apr 25, 2016 266
diabetes d-day; Massive Scottish clinical drug trial aims to prevent children developing Type 1 illness. Apr 20, 2016 424
First patient treated in diabetes Phase 2 trial. Clinical report Apr 11, 2016 444
First patient treated in diabetes phase 2 trial. Clinical report Apr 4, 2016 443
First patient treated in diabetes phase 2 trial. Clinical report Apr 4, 2016 444
Pancreatic cancer clinical trial. Mar 1, 2016 522
Tobira Therapeutics completes recruitment for Phase 2a ORION study. Clinical report Feb 11, 2016 212
Tobira Therapeutics completes recruitment for Phase 2a ORION study. Clinical report Feb 11, 2016 208
United States : ZOSANO PHARMA'S ZP-Glucagon Patch Phase 2 Study obtains Better outcomes. Clinical report Oct 16, 2015 213
Caladrius, Sanford Research to develop treatment for type 1 diabetes. Oct 12, 2015 144
Caladrius, Sanford Research to develop treatment for type 1 diabetes. Oct 5, 2015 144
Collaboration to develop treatment for type 1 diabetes. Oct 5, 2015 144
provision of over-encapsulated sitagliptin (januvia), pioglitazone (actos) and cangliflozin (invokana) for double-blind randomised/clin trials. Aug 17, 2015 232
GI Dynamics Discontinues US EndoBarrier Trial. Jul 30, 2015 402
"Gestational Diabetes Global Clinical Trials Review, H1, 2015" Published. Jul 29, 2015 312
First Patients Enrolled in Multicenter Clinical Trial of Fractyl Revita DMR System. Jul 16, 2015 262
Take a look at the firms the place to be when you showing why Wales is are going for growth. Apr 15, 2015 1705
Rhythm starts Phase IIb clinical trial of relamorelin. Apr 10, 2015 167
Rhythm starts Phase IIb clinical trial of relamorelin. Apr 10, 2015 163
Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial. koujan, Soraiya Ebrahimpour; Gargari, Bahram Pourghassem; Mobasseri, Majid; Valizadeh, Hadi; Asghari Report Feb 15, 2015 6893
Tobira Therapeutics starts dosing in Phase I trial of cenicriviroc and pioglitazone. Jan 22, 2015 150
Tobira Therapeutics starts dosing in Phase I trial of cenicriviroc and pioglitazone. Jan 22, 2015 146
Tobira Therapeutics doses first subject in Phase 1 clinical trial of cenicriviroc and pioglitazone for NASH and liver fibrosis, including Type 2 diabetes mellitus. Jan 21, 2015 239
Tobira Therapeutics doses first subject in Phase 1 clinical trial of cenicriviroc and pioglitazone for NASH and liver fibrosis, including Type 2 diabetes mellitus. Jan 21, 2015 235
Recent advances in dipeptidyl-peptidase-4 inhibition therapy: lessons from the bench and clinical trials. Zhong, Jixin; Gong, Quan; Goud, Aditya; Srinivasamaharaj, Srividya; Rajagopalan, Sanjay Jan 1, 2015 11922
Boston Therapeutics submits investigational new drug application for clinical trial of BTI-320 to US Food and Drug Administration. Dec 12, 2014 134
Boston Therapeutics submits investigational new drug application for clinical trial of BTI-320 to US Food and Drug Administration. Dec 12, 2014 130
Clinical trial to test safety of stem cell-derived therapy for type 1 diabetes. Sep 15, 2014 454
FDA accepts IND to begin clinical trial of cell replacement therapy for type 1 diabetes. Sep 15, 2014 310
FDA accepts IND to begin clinical trial of therapy for type 1 diabetes. Sep 8, 2014 309
FDA accepts IND to begin clinical trial of therapy for type 1 diabetes. Sep 8, 2014 311
Cardiovascular risks overlooked in antidiabetes drug trials. Kessler, A. Brief article Sep 1, 2014 178
Oramed Pharmaceuticals treats last patient with ORMD-0801 in Phase IIa trial for type 1 diabetes. Aug 8, 2014 161
Oramed Pharmaceuticals treats last patient with ORMD-0801 in Phase IIa trial for type 1 diabetes. Aug 8, 2014 165
ViaCyte files Investigational New Drug application to start Phase 1/2 clinical trial to treat type 1 diabetes. Jul 21, 2014 263
ViaCyte files Investigational New Drug application to start Phase 1/2 clinical trial to treat type 1 diabetes. Jul 21, 2014 259
United States : Pharma improves care by sharing clinical trial data. Jun 18, 2014 437
Phase III data: canagliflozin effects include weight loss. Mechcatie, Elizabeth Clinical report Jun 1, 2014 453
United Kingdom : Benefits of clinical trials celebrated in Wales. May 21, 2014 510
ORAMED COMPLETES FDA PHASE 2A CLINICAL TRIAL. Apr 1, 2014 144
Celladon options SERCA2b modulators development agreement with Servier. Feb 25, 2014 213
Celladon options SERCA2b modulators development agreement with Servier. Feb 25, 2014 209
Oramed Pharmaceuticals files protocol to start Phase IIa trial of ORMD 0801 for type 1 diabetes. Feb 12, 2014 134
Oramed Pharmaceuticals files protocol to start Phase IIa trial of ORMD 0801 for type 1 diabetes. Feb 12, 2014 130
MannKind Corporation submits NDA to US FDA to seek AFREZZA 's approval to treat adults with type 1 or type 2 diabetes. Oct 14, 2013 251
MannKind Corporation submits NDA to US FDA to seek AFREZZA 's approval to treat adults with type 1 or type 2 diabetes. Oct 14, 2013 247
SWITZERLAND - Metformin for treatment of polycystic ovary syndrome in children. (METFIZZ). Disease/Disorder overview Oct 3, 2013 371
Type 1 Diabetes Drug Strikingly Effective in Clinical Trial. Aug 18, 2013 793
Medistem (OTCMKTS:MEDS), Enters Collaboration with Boston Academic Teaching Hospital to Expand Preclinical Data in Type 1 Diabetes. Jul 30, 2013 322
Canagliflozin bests sitagliptin for type 2 DM in comparative trial: rates of UTIs did not differ between the treatment groups. Jancin, Bruce Jul 1, 2013 835
Roche halts studies of experimental type 2 DM drug. Mechcatie, Elizabeth Jul 1, 2013 391
Sanofi reports positive Phase 3 data for Lixisenatide for Type 2 diabetes as a once dally treatment. Jun 24, 2013 320
Sanofi reports positive Phase 3 data for Lixisenatide for Type 2 diabetes as a once dally treatment. Jun 24, 2013 316
Rhythm starts phase 2 trial of RM-493 in obese patients. Jan 8, 2013 110
Rhythm starts phase 2 trial of RM-493 in obese patients. Jan 8, 2013 106
1st human clinical trial of artificial pancreas yields positive result. Jun 11, 2012 514
Insulin degludec matches glargine efficacy: nocturnal hypoglycemic episode rates significantly lower with insulin degludec in two phase III trials. Moon, Mary Ann May 15, 2012 913
GSK to file for diabetes drug after new trials. Apr 3, 2012 362
Clinical trial to begin of company's new diabetes management system; WIRELESS TECHNOLOGY TO BE USED TO MONITOR 100 AFFECTED PATIENTS. Feb 10, 2012 665
NEJM publishes Diamyd Medical's Phase III trial data. Feb 2, 2012 160
Mesoblast Limited (ASX:MSB) FDA Clearance for Phase 2 Clinical Trial in Type 2 Diabetes. Jan 31, 2012 943
FDA approves Mesoblasta[euro](tm)s Phase II Type 2 diabetes study. Jan 31, 2012 192
Omni Bio to conduct new human clinical trials with Alpha-1 antitrypsin for Type 1 diabetes & GVHD treatment. Jan 16, 2012 152
Omni Bio to start new Type 1 diabetes, GVHD trials. Jan 13, 2012 127
-Sanofi announces positive Phase III data for Zealand Pharma's Lyxumia. Dec 8, 2011 272
-Sanofi announces positive Phase III data for Zealand Pharma's Lyxumia. Dec 8, 2011 273
Takeda begins Phase III study programme for Type 2 diabetes treatment TAK-875. Oct 18, 2011 239
Catabasis begins Phase I study of Type 2 diabetes compound. Oct 6, 2011 114
Bristol-Myers, AstraZeneca report Phase IIIb data with ONGLYZA in Type 2 diabetes. Clinical report Sep 16, 2011 213
-Zealand Pharma announces preclinical data on type 2 diabetes drug. Jun 28, 2011 192
-Zealand Pharma announces preclinical data on type 2 diabetes drug. Jun 28, 2011 191
-AstraZeneca issues Phase III extension data on diabetes drug. Jun 27, 2011 252
-AstraZeneca issues Phase III extension data on diabetes drug. Jun 27, 2011 254
Generic drug BCG 'reverses type 1 diabetes in a phase 1 human trial'. Jun 27, 2011 409
Zealand Pharma's partner reports Phase III data with Lyxumia for Type 2 diabetes. May 31, 2011 230
-Swedish Diamyd Medical says diabetes drug fails in European phase III study. May 9, 2011 337
-Swedish Diamyd Medical says diabetes drug fails in European phase III study. May 9, 2011 338
Final patient completes EU Phase III study of Diamyd in Type 1 diabetes. Feb 14, 2011 323
Takeda initiates enrollment in Phase III study of alogliptin in China. Feb 9, 2011 178
-Zealand Pharma says Sanofi-Aventis issues positive phase III data with diabetes drug. Feb 2, 2011 146
-Zealand Pharma says Sanofi-Aventis issues positive phase III data with diabetes drug. Feb 2, 2011 147
Journal abstracts: metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. Brief article Nov 1, 2010 236
New phase III data further support the safety and efficacy profile of Boehringer IngelheimEoACAOs investigational drug linagliptin. Sep 22, 2010 246
Landmark ACCORD Trial Finds Intensive Blood Pressure and Combination Lipid Therapies do not Reduce Combined Cardiovascular Events in Adults with Diabetes. Mar 15, 2010 169
Partnerships created to develop insulin delivery systems. Tucker, Miriam E. Feb 15, 2010 468
Osiris completes enrollment in Type 1 diabetes study. Jan 25, 2010 209
Lexicon reports Phase II study data for LX4211 in Type 2 diabetes. Clinical report Jan 20, 2010 491
Spherix completes enrollment in Phase III study of D-tagatose in Type 2 diabetes. Clinical report Jan 14, 2010 383
Biodel submits NDA for VIAject for treatment of diabetes. Dec 31, 2009 170
Biocon limited, Amylin pharmaceuticals enter global development agreement. Sep 11, 2009 299
BMS/AZ diabetes drug approved: Lilly cancels osteoporosis drug in Phase III. Sep 1, 2009 2717
For Safety, NHLBI Changes Intensive Blood Sugar Treatment Strategy in Clinical Trial of Diabetes and Cardiovascular Disease. Feb 6, 2008 113
Monotherapy option for type 2 diabetes patients: muraglitazar effectively lowered hemoglobin [A.sub.1c] and triglycerides while raising HDL cholesterol levels. Tucker, Miriam E. Jul 1, 2005 973
Hemoglobin [A.sub.1C] measurements over nearly two decades: sustaining comparable values throughout the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Steffes, Michael; Cleary, Patricia; Goldstein, David; Little, Randie; Wiedmeyer, Hsiao-Mei; Rohlfing Apr 1, 2005 3900
Approach to maintaining comparability of biochemical data during long-term clinical trials. Cull, Carole A.; Manley, Susan E.; Stratton, Irene M.; Neil, H. Andrew W.; Ross, Iain S.; Holman, Ru Clinical report Oct 1, 1997 3826

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters